Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1974 Aug;54(2):310–315. doi: 10.1172/JCI107766

Inhibition of In Vivo Insulin Secretion by Prostaglandin E1

R Paul Robertson 1,2, David J Gavareski 1,2, Daniel Porte Jr 1,2, Edwin L Bierman 1,2
PMCID: PMC301558  PMID: 4847247

Abstract

To determine the effect of prostaglandin E1 (PGE1) infusion upon in vivo insulin secretion, serum insulin responses after an intravenous glucose pulse (2 g) were measured before and during an intravenous infusion of PGE1 (10 μg/min) in 11 anesthetized dogs. Circulating insulin decreased significantly during PGE1 infusion were significantly less than control responses. Three dogs received PGE1 infusions into the thoracic aorta to preclude pulmonic and hepatic degradation of PGE1 before its arrival at the pancreatic artery; inhibition of insulin secretion was again seen. Inhibition of insulin secretion could not be related to the degree of arterial hypotension induced by intravenous PGE1, and despite alpha adrenergic blockade with intravenous phentolamine, PGE1-induced inhibition of glucose-stimulated insulin responses persisted. Significant increments in systemically circulating PGE levels during intravenous PGE1 infusions were documented by radioimmunoassay. These studies demonstrate that systemic PGE1 infusion inhibits insulin secretion and that this effect could not be shown to be dependent upon alpha adrenergic activity.

Full text

PDF
310

Images in this article

312Image
on p.312
313Image
on p.313

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allison S. P., Chamberlain M. J., Hinton P. Intravenous glucose tolerance, insulin, glucose, and free fatty acid levels after myocardial infarction. Br Med J. 1969 Dec 27;4(5686):776–778. doi: 10.1136/bmj.4.5686.776. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bressler R., Vargas-Cord M., Lebovitz H. E. Tranylcypromine: a potent insulin secretagogue and hypoglycemic agent. Diabetes. 1968 Oct;17(10):617–624. doi: 10.2337/diab.17.10.617. [DOI] [PubMed] [Google Scholar]
  3. Ferreira S. H., Vane J. R. Prostaglandins: their disappearance from and release into the circulation. Nature. 1967 Dec 2;216(5118):868–873. doi: 10.1038/216868a0. [DOI] [PubMed] [Google Scholar]
  4. Hertelendy F., Todd H., Ehrhart K., Blute R. Studies on growth hormone secretion. IV. In vivo effects of prostaglandin E1. Prostaglandins. 1972 Aug;2(2):79–91. doi: 10.1016/0090-6980(72)90041-x. [DOI] [PubMed] [Google Scholar]
  5. Johnson D. G., Fujimoto W. Y., Williams R. H. Enhanced release of insulin by prostaglandins in isolated pancreatic islets. Diabetes. 1973 Sep;22(9):658–663. doi: 10.2337/diab.22.9.658. [DOI] [PubMed] [Google Scholar]
  6. Lefebvre P. J., Luyckx A. S. Stimulation of insulin secretion after prostaglandin PGE 1 in the anesthetized dog. Biochem Pharmacol. 1973 Jul 15;22(14):1773–1779. doi: 10.1016/0006-2952(73)90391-2. [DOI] [PubMed] [Google Scholar]
  7. Porte D., Jr A receptor mechanism for the inhibition of insulin release by epinephrine in man. J Clin Invest. 1967 Jan;46(1):86–94. doi: 10.1172/JCI105514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Robertson R. P., Porte D., Jr The glucose receptor. A defective mechanism in diabetes mellitus distinct from the beta adrenergic receptor. J Clin Invest. 1973 Apr;52(4):870–876. doi: 10.1172/JCI107251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Saccà L., Rengo F., Chiariello M., Condorelli M. Glucose intolerance and impaired secretion by prostaglandin A1 in fasting anesthetized dogs. Endocrinology. 1973 Jan;92(1):31–34. doi: 10.1210/endo-92-1-31. [DOI] [PubMed] [Google Scholar]
  10. Spellacy W. N., Buhi W. C., Holsinger K. K. The effect of prostaglandin F 2 and E 2 on blood glucose and plasma insulin levels during pregnancy. Am J Obstet Gynecol. 1971 Sep 15;111(2):239–243. doi: 10.1016/0002-9378(71)90896-9. [DOI] [PubMed] [Google Scholar]
  11. Taylor S. H., Saxton C., Majid P. A., Dykes J. R., Ghosh P., Stoker J. B. Insulin secretion following myocardial infarction with particular respect to the pathogenesis of cardiogenic shock. Lancet. 1969 Dec 27;2(7635):1373–1378. doi: 10.1016/s0140-6736(69)90928-3. [DOI] [PubMed] [Google Scholar]
  12. Zusman R. M., Caldwell B. V., Speroff L., Behrman H. R. Radioimmunoassay of the A prostaglandins. Prostaglandins. 1972 Jul;2(1):41–53. doi: 10.1016/0090-6980(72)90028-7. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES